MoncadaS, HiggsEA. Molecular mechanisms and therapeutic strategies related to nitric oxide (review). FASEB J1995;9(13):1319–1330.
3.
RobertsJD, PolanerDM, LangP, ZapolWM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet1992;340(8823):818–819.
4.
Neonatal Inhaled Nitric Oxide Study Group (NINOS). Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med1997;336(9):597–604.
5.
RossaintR, FalkeKJ, LopezF, SlamaK, PisonU, ZapolWM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med1993;328(6):399–405.
6.
GerlachH, RossaintR, PappertD, FalkeKJ. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest1993;23(8):499–502.
7.
FrostellCG, BlomqvistH, HedenstiernaG, LundbergJ, ZapolWM. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology1993;78(3):427–435.
8.
ZapolWM, RimarS, GillisN, MarlettaM, BoskenCH. Nitric oxide and the lung. Am J Respir Crit Care Med1994;149(5):1375–1380.
9.
RobertsJDJr, FinemanJR, MorinFC3rd, ShaulPW, RimarS, SchreiberMD, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med1997;336(9):605–610.
RimarS, GillisCN. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation1993;88(6):2884–2887.
12.
GabouryJ, WoodmanRC, GrangerDN, ReinhardtP, KubesP.Nitric oxide prevents leukocyte adherence: role of superoxide. Am J Physiol1993;265(3 Pt 2):H862–H867.
13.
StamlerJS, JiaL, EuJP, McMahonTJ, DemchenkoIT, BonaventuraJ, et al. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science1997;276(5321):2034–2037.
14.
ThomassenMJ, BohrowLT, ConnorsMJ, KanekoFT, ErgurumSC, KavuruMS, et al. Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophageslpage>. Am J Respir Cell Mol Biol1997;17(3):279–283.
15.
SamamaCM, DiabyM, FellahiJL, MdhafarA, EyraudD, ArockM, et al. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology1995;83(1):56–65.
BunnHF. Pathogenesis and treatment of sickle cell disease (review). N Engl J Med1997;337(11):762–769.
20.
KaulDK, NagelRL. Sickle cell vasoocclusion: many issues and some answers (review). Experientia1993;49(1):5–15.
21.
FabryME, KaulD.Sickle cell vaso-occlusion (review). Hematol Oncol Clin North Am1991;5(3):375–398.
22.
SettyBN, StuartMJ. Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease. Blood1996;88(6):2311–2320.
23.
HeadCA. Nitric oxide and the lung: an overview (review). Artif Organs1997;21(1):5–9.
24.
ToothillC.The chemistry of the in vivo reaction between haemoglobin and various oxides of nitrogen. Br J Anaesth1967;39(5):405–412.
25.
JiaL, BonaventuraC, BonaventuraJ, StamlerJS. S-nitrosohaemoglobin. a dynamic activity of blood involved in vascular control. Nature1996;380(6571):221–226.
26.
SunshineHR, HofrichterJ, EatonWA. Requirement for therapeutic inhibition of sickle haemoglobin gelation. Nature1978;275(5677):238–240.
27.
TrudelM, De PaepeME, ChretienN, SaadaneN, JacmainJ, SoretteM, et al. Sickle cell disease of transgenic SAD mice. Blood1994;84(9):3189–3197.
28.
De FuriaFG, MillerDR, CeramiA, ManningJM. The effects of cyanate in vitro on red blood cell metabolism and function in sickle cell anemia. J Clin Invest1972;51(3):566–574.
29.
BuetlerE.The effect of carbon monoxide on red cell life span in sickle cell disease. Blood1975;46(2):253–259.
KonK, MaedaN, ShigaT.Effect of nitric oxide on the oxygen transport of human erythrocytes. J Toxicol Environ Health1977;2(5):1109–1113.
32.
HeadCA, BrugnaraC, Martinez-RuizR, KacmarekRM, BridgesKR, KuterD, et al. Low concentrations of nitric oxide increases oxygen affinity of sickle erythrocytes in vitro and in vivo. J Clin Invest1997;100(5):1193–1198.
33.
PoillonWN, RobinsonMD, KimBC. Deoxygenated sickle hemoglobin: modulation of its solubility by 2, 3-diphosphoglycerate and other allosteric polyanions. J Biol Chem1985;260(26):13897–13900.
34.
MooreEG, GibsonQH. Cooperativity in the dissociation of nitric oxide from hemoglobin. J Biol Chem1976;251(9):2788–2794.
35.
Pepke-ZabaJ, HigenbottamTW, Dinh-XuanAT, StoneD, WallworkJ.Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet1991;338(8776):1173–1174.
36.
BriehlRW, SalhanyJM. Gelation of sickle hemoglobin. III. Nitrosyl hemoglobin. J Mol Biol1975;96(4):733–743.
37.
MoriguchiM, ManningLR, ManningJM. Nitric oxide can modify amino acid residues in proteins. Biochem Biophys Res Commun1992;183(2):598–604.
38.
StamlerJS, SingelDJ, LoscalzoJ.Biochemistry of nitric oxide and its redox-activated forms (review). Science1992;258(5090):1898–1902.
39.
HaranoK, HaranoT, ShibataS, UedaS, MoriH, SekiM.Hb Okazaki [beta 93(F8) Cys-Arg], a new hemoglobin variant with increased oxygen affinity and instability. FEBS Lett1984;173(1):45–47.
40.
AtzAM, WesselDL. Inhaled nitric oxide in sickle cell disease with acute chest syndrome. Anesthesiology1997;87(4):988–990.
41.
StamlerJS, LohE, RoddyMA, CurrieKE, CreagerMA. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation1994;89(5):2035–2040.
42.
PinskyDJ, NakaY, ChowdhuryNC, LiaoH, OzMC, MichlerRE, et al. The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation. Proc Natl Acad Sci USA1994;91(25):12086–12090.
43.
BachaEA, HeadCA. Use of inhaled nitric oxide for lung transplantation and cardiac surgery (review). Respir Care Clin N Am1997;3(4):521–536.
44.
NakaY, ChowdhuryNC, OzMC, SmithCR, YanoOJ, MichlerRE, et al. Nitroglycerin maintains graft vascular homeostasis and enhances preservation in an orthotopic rat lung transplant model. J Thorac Cardiovasc Surg1995;109(2):206–211.
45.
MurakamiS, BachaEA, HerveP, DetruitH, ChapelierAR, DartevellePG, MazmanianGM. Prevention of reperfusion injury by inhaled nitric oxide in lungs harvested from non-heart-beating donors. Paris-Sud University Lung Transplantation Group. Ann Thorac Surg1996;62(6):1632–1638.
46.
OzMC, PinskyDJ, KogaS, LiaoH, BarboeCC, HanD, et al. Novel preservation solution permits 24-hour preservation in rat and baboon cardiac transplant models. Circulation1993;88(5 Pt 2):II291–II297.
47.
HogmanM, FrostellC, ArnbergH, SandhagenB, HedenstiernaG.Prolonged bleeding time during nitric oxide inhalation in the rabbit. Acta Physiol Scand1994;151(1):125–129.
48.
NeumannFJ, MarxN, GawazM, BrandK, OttI, RokittaC, et al. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation1997;95(10):2387–2394.
49.
DuranteW, KrollMH, ChristodoulidesN, PeytonKJ, SchaferAI. Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res1997;80(4):557–564.
50.
AdrieC, BlochKD, MorenoPR, HurfordWE, GuerreroJL, HoltR, et al. Inhaled nitric oxide increases coronary artery patency after thrombolysis. Circulation1996;94(8):1919–1926.
51.
Lopez-FarreA.The role of nitric oxide in blood cell interaction. Methods Find Exp Clin Pharmacol1997;19(Suppl A):17–21.
52.
KanwarS, KubesP.Nitric oxide is an anti-adhesive molecule for leukocytes (review). New Horiz1995;3(1):93–104.
53.
BathPMW, HasallDG, GladwinAM, PalmerRM, MartinJF. Nitric oxide and prostacyclin: divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler Thromb1991;11(2):254–260.
